Study of Dolutegravir and Darunavir/Cobicistat for endothelial glycocalyx integrity measurement in diagnosed and treatment naive HIV patients
Latest Information Update: 12 Oct 2022
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
Most Recent Events
- 12 Oct 2022 New trial record
- 29 Aug 2022 Results presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology